After more than 20 years of managing private investments for the Howard Hughes Medical Institute, Mark A. Barnard has decided to step down as Managing Director of Private Investments, effective June 2016. Trusted Insight interviewed Barnard in December 2015 after naming him as one of the Top 30 Healthcare Institutional Investors. You can read that interview here.
Barnard joined HHMI in 1995 after 10 years in the MIT Treasurers Office, and was responsible for a portfolio of global private equity, venture capital, real assets and natural resources. He led a team of three directors and was a member of the senior management team of the Institute. HHMI is a medical research organization whose mission is to advance biomedical research and science education for the benefit of humanity.
“It’s been an honor and a privilege to have worked at HHMI all of these years and been part of an investment team that created investment returns in support of the Institute’s incredible mission of scientific research and education,” said Barnard. “I will miss the interaction with my many friends and colleagues around the world working in the private equity industry, but I look forward to opening a new chapter in my personal and professional life.”
Barnard will remain involved with the Institute as a part-time advisor to the endowment fund through the end of November 2016 and can be reached via his current contact information until then.
Greg DeNinno, currently Director of Private Investments at HHMI, will succeed Barnard as Managing Director of Private Investments, effective June 2016. DeNinno joined the Institute in 2008 as an analyst and was promoted to Director of Private Investments in 2009. Previously, he worked on acquisitions at Intelsat. At HHMI, DeNinno focused on European private equity, venture and small cap buyouts. DeNinno will be looking to add an experienced director to the team.
Click here to see who else was named to Trusted Insight's ranked list of Top 30 Healthcare Institutional Investors.
Barnard joined HHMI in 1995 after 10 years in the MIT Treasurers Office, and was responsible for a portfolio of global private equity, venture capital, real assets and natural resources. He led a team of three directors and was a member of the senior management team of the Institute. HHMI is a medical research organization whose mission is to advance biomedical research and science education for the benefit of humanity.
“It’s been an honor and a privilege to have worked at HHMI all of these years and been part of an investment team that created investment returns in support of the Institute’s incredible mission of scientific research and education,” said Barnard. “I will miss the interaction with my many friends and colleagues around the world working in the private equity industry, but I look forward to opening a new chapter in my personal and professional life.”
Barnard will remain involved with the Institute as a part-time advisor to the endowment fund through the end of November 2016 and can be reached via his current contact information until then.
Greg DeNinno, currently Director of Private Investments at HHMI, will succeed Barnard as Managing Director of Private Investments, effective June 2016. DeNinno joined the Institute in 2008 as an analyst and was promoted to Director of Private Investments in 2009. Previously, he worked on acquisitions at Intelsat. At HHMI, DeNinno focused on European private equity, venture and small cap buyouts. DeNinno will be looking to add an experienced director to the team.
Click here to see who else was named to Trusted Insight's ranked list of Top 30 Healthcare Institutional Investors.